The binding of prorenin to PRR triggers the phosphorylation of mitogen-activated protein kinases/extracellular regulated kinases 1/2 (MAPK/ERK1/2), which is demonstrated to be an ANG II-independent mechanism involved in the development of diabetic nephropathy ( The ANGIV/AT4/IRAP cascade: ANG IV (derived from the metabolization of ANG II through aminopeptidases A and N) binds the AT4 receptor, which has been identified as the insulin-regulated aminopeptidase (IRAP), but the role of this pathway in the blood pressure and renal regulation is still uncertain ( These new axes have raised great interest because their targeting could provide novel therapeutic strategies for hypertension, cardiovascular and kidney diseases
They: Increase glucose-dependent insulin secretion Suppress glucagon (a hormone produced by the pancreas that raises blood sugar levels) Slow gastric (stomach) emptying Act on the brain to curb appetite and enhance satiety Common GLP-1s include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and others
What the Research Shows Clinical pharmacokinetic observations for semaglutide consistently indicate that abdominal injections produce the most reliable and complete absorption compared to other sites
Most of them are taken in a self-administered injectable format
